PMID- 36911651 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230314 IS - 2050-0904 (Print) IS - 2050-0904 (Electronic) IS - 2050-0904 (Linking) VI - 11 IP - 3 DP - 2023 Mar TI - Multiple endocrine neoplasia type 1 familial case in a patient with insulinoma and primary hyperparathyroidism: First report in literature and in the Costa Rican population of the c.1224_1225insGTCC pathogenic variant. PG - e7041 LID - 10.1002/ccr3.7041 [doi] LID - e7041 AB - Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal dominant disorder without a good genotype-phenotype correlation, characterized by tumor predisposition in the parathyroid gland, anterior pituitary, and pancreatic islet cells. Here, we describe a 37-year-old male with previous history of nephrolithiasis, with a 1-year history of recurrent hypoglycemic episodes. Physical examination revealed the presence of two lipomas. Family history revealed primary hyperparathyroidism (PHPT), hyperprolactinemia, and multiple non-functioning pancreatic neuroendocrine tumors. Initial laboratories revealed hypoglycemia and primary hyperparathyroidism. A fasting test was positive after 3 hours of initiation. An abdominal CT Scan demonstrated a 28 x 27 mm mass in the pancreatic tail and bilateral nephrolithiasis. A distal pancreatectomy was done. After surgery, the patient persisted with hypoglycemic episodes that were managed with diazoxide and frequent feedings. A parathyroid Tc-99 m MIBI scan with SPECT/CT imaging demonstrated two hot uptake lesions compatible with abnormally functioning parathyroid tissue. Surgical treatment was offered; however, the patient decided to postpone the procedure. Direct sequence analysis of MEN1 gene revealed heterozygosity for a pathogenic insertion c.1224_1225insGTCC (p.Cys409Valfs*41). DNA sequence analysis was done to six of his first-degree relatives. A sister with clinical diagnosis of MEN1 and a pre-symptomatic brother were positive for the same MEN1 variant. To our knowledge, this is the first report of a genetically confirmed case of MEN1 in our country and is the first report in literature of the c.1224_1225insGTCC variant related to a clinically affected family. CI - (c) 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. FAU - Molina-Cespedes, Paula AU - Molina-Cespedes P AD - Escuela de Medicina Universidad de Costa Rica San Jose Costa Rica. FAU - Ruiz-Golcher, Ernesto Jose AU - Ruiz-Golcher EJ AD - Escuela de Medicina Universidad de Costa Rica San Jose Costa Rica. FAU - Badilla-Barboza, Oscar AU - Badilla-Barboza O AD - Medico Endocrinologo Hospital San Juan de Dios San Jose Costa Rica. FAU - Sedo-Mejia, Giovanni AU - Sedo-Mejia G AD - Unidad de Alergologia Hospital San Juan de Dios San Jose Costa Rica. FAU - Barboza-Rodriguez, Laura AU - Barboza-Rodriguez L AD - Servicio de Anatomia Patologica Hospital San Juan de Dios San Jose Costa Rica. FAU - Badilla-Porras, Ramses AU - Badilla-Porras R AUID- ORCID: 0000-0001-9209-1779 AD - Servicio de Genetica y Metabolismo Hospital Nacional de Ninos San Jose Costa Rica. LA - eng PT - Case Reports DEP - 20230308 PL - England TA - Clin Case Rep JT - Clinical case reports JID - 101620385 PMC - PMC9994136 OTO - NOTNLM OT - endocrine and metabolic disorders OT - familial OT - genetics OT - hypoglycemia OT - insulinoma OT - multiple endocrine neoplasia OT - nephrolithiasis OT - oncology OT - primary hyperparathyroidism COIS- The authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria, educational grants, participation in speakers' bureaus, membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript. EDAT- 2023/03/14 06:00 MHDA- 2023/03/14 06:01 PMCR- 2023/03/08 CRDT- 2023/03/13 04:28 PHST- 2020/06/07 00:00 [received] PHST- 2023/01/27 00:00 [revised] PHST- 2023/02/13 00:00 [accepted] PHST- 2023/03/13 04:28 [entrez] PHST- 2023/03/14 06:00 [pubmed] PHST- 2023/03/14 06:01 [medline] PHST- 2023/03/08 00:00 [pmc-release] AID - CCR37041 [pii] AID - 10.1002/ccr3.7041 [doi] PST - epublish SO - Clin Case Rep. 2023 Mar 8;11(3):e7041. doi: 10.1002/ccr3.7041. eCollection 2023 Mar.